Cardiomyopathy Trial, Recruiting (NCT07372196)

Cardiomyopathy Trial, Recruiting NCT07372196 Sponsor: Meshalkin Research Institute of Pathology of Circulation Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07372196 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man or woman aged 18 years or older
You have a heart condition called HCM (hypertrophic cardiomyopathy) and have previously had a surgical procedure called a myectomy, after which you developed a specific type of abnormal heart electrical pattern (called LBBB) with a certain measurement on your heart tracing (QRS complex greater than 130 ms), and you are considered at high risk of sudden cardiac death (confirm with trial site)
You have signed a consent form agreeing to take part in the study

Who may not be able to join:

Your heart electrical tracing does not show the specific pattern required, or your QRS measurement is less than 130 ms
You already have a different type of permanent abnormal electrical pattern in your heart (called complete RBBB) before the study begins
You are planned to have a heart transplant or a special heart pump device (LVAD) implanted within the next 6 months
You are considered at intermediate or low risk of sudden cardiac death
You had a heart attack less than three months before joining the study
You are currently experiencing acute (sudden and severe) kidney or liver failure
You currently have a serious active infection
You have a diagnosed mental illness
You have another illness where life expectancy is less than one year
You decide at any point that you no longer wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +79044714203

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07372196

Sponsor: Meshalkin Research Institute of Pathology of Circulation

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +79044714203

More information: https://clinicaltrials.gov/study/NCT07372196

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man or woman aged 18 years or older
You have a heart condition called HCM (hypertrophic cardiomyopathy) and have previously had a surgical procedure called a myectomy, after which you developed a specific type of abnormal heart electrical pattern (called LBBB) with a certain measurement on your heart tracing (QRS complex greater than 130 ms), and you are considered at high risk of sudden cardiac death (confirm with trial site)
You have signed a consent form agreeing to take part in the study

Who may not be able to join:

Your heart electrical tracing does not show the specific pattern required, or your QRS measurement is less than 130 ms
You already have a different type of permanent abnormal electrical pattern in your heart (called complete RBBB) before the study begins
You are planned to have a heart transplant or a special heart pump device (LVAD) implanted within the next 6 months
You are considered at intermediate or low risk of sudden cardiac death
You had a heart attack less than three months before joining the study
You are currently experiencing acute (sudden and severe) kidney or liver failure
You currently have a serious active infection
You have a diagnosed mental illness
You have another illness where life expectancy is less than one year
You decide at any point that you no longer wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Meshalkin Research Institute of Pathology of Circulation

Registry

ClinicalTrials.gov

Start date

14 November 2025

Est. completion

1 May 2027

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Serious Adverse Events; Efficiency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov